Eligibility for liraglutide for weight loss is: Body Mass Index BMI 30 or higher or 27 or higher with weight related condition
Patients should be monitored for diabetic retinopathy complications (especially if on insulin with rapid HbA1c improvement), gallbladder disease, and signs of dehydration or acute kidney injury
73.1% Projected increase in GLP-1 utilization for weight loss by the end of the year
How Peptide Therapy Works Peptide therapy is grounded in cutting-edge research highlighting the body's ability to heal itself when provided with the right biochemical support
Suboxone is a popular prescription medication approved by the Food & Drug Administration (FDA) to treat Opioid use disorder (OUD)
These medications help regulate blood sugar, control appetite, and promote weight loss, but their effects are most significant when used alongside lifestyle changes, such as diet and exercise